(Seoul = International News) Reporter Kim Tae-yeop = AdipoLABs Co., Ltd. has announced on the 14th that there would be a seminar on the effect of hyperthermia and case report on the 15th at Seoul COEX during KIMES 2019 (The 35th Korea International Medical & Hospital Equipment Show)
The seminar is hosted by AdipoLABs, a manufacturer of high-frequency hyperthermia cancer treatment device (REMISSION 1 ℃), and the Korean Society for Thermal Medicine.
Many representatives from over 20 countries, including Japan, India, Malaysia, Indonesia, Thailand, China and the Philippines, expressed their strong interest in 'hyperthermia', which is now rising as one of the world's new cancer therapies.Among the figures were Ambassador YUSUF SHARIFZODA from the Embassy of Tajikistan, DANIELA PETROVA, Managing Director of the Bulgarian Embassy, Nurmatjon Komilov of the Trade Representative of Uzbekistan, CLAUDIA FIFEA, of the Romanian Embassy, and Diaa Ham of the Egyptian Embassy, Dr. MOHAMED JINNA, Chairman of the UNWHD, Dr. NAGRAJ G. HUILGOL, Chairman of Radiology Oncology at Nanabati Hospital in Mumbai, India, and the president of the WBC World's State-of-the-Art Brain Neurology Institute in Japan who is also the chairman of the Institute of Ultra-light Quantum Mechanics. Medical officials and buyers from different countries will also participate.
The seminar will be attended by Il-bong Choi, Chairman of the Korean Society for Thermal Medicine and Asian Oncology Tumor, and Professor Tae-jin Song of Liver Pancreatic Surgery in Ansan Hospital of Korea University. Five hyperthermia scholars will participate as speakers.
The first speaker, Professor Hwa-seung Yoo of the East-West Cancer Center in Dunsan Oriental Hospital of Daejeon University, will give a lecture on the cases related to chemotherapy and oriental medicine treatment with high-frequency heat cancer treatment under the theme of 'Latest tumor immunology and high-frequency heat treatment'.
In the lecture of Professor Young-Nam Kang of the Department of Radiation Oncology at Catholic University College of Medicine, he will have presented the principles of high-frequency thermal cancer treatment and information on high-frequency thermal cancer treatment devices. The patient's statistics about treatment with high-frequency hyperthermia cancer treatment device (REMISSION 1℃) will be introduced as well.
The third speaker, Professor Jong-Chun Ju of the Department of Physical Constitution and Physiology at Wonkwang University, will give a lecture on the case analysis of high frequency hyperthermia therapy for various cancers and also introduce moxibustion therapy which is a kind of heat treatment.
In the lecture of the fourth speaker, Dr. Hong-Seok Jang from the Department of Radiation Oncology at Catholic University, Efficacy and Cases of High-frequency Hyperthermia Cancer Treatment will be covered along with the results of treatment with REMISSION 1 ℃ on various patients.
In the lecture of the 5th speaker, Ihl-bohng Choi who is the Chairman of the Korean Society for Thermal Medicine and the Chairman of the Asian Society for Thermal Oncology, the topic of 'immune and heat therapy' and the increased immunity according to vitalized NK cells (natural killer cells) along with the treatment of high-frequency hyperthermia will be covered. Patient cases and increased levels of NK cell activation after the treatment of hyperthermia device, REMISSION 1℃ will also be introduced.
